We collected information about Beam Therapeutics Inc Hours for you. Follow the liks to find out everything about Beam Therapeutics Inc Hours.
BEAM-101 IND Cleared by FDA for Evaluation as a Treatment for Sickle Cell Disease BEAM-102 IND-Enabling Studies Also Underway CAMBRIDGE, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base ...
https://www.nasdaq.com/market-activity/stocks/beam/after-hours
Beam Therapeutics Inc. Common Stock (BEAM) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
https://etfdailynews.com/news/beam-therapeutics-inc-beam-price-now-near-70-81-daily-chart-shows-downtrend-on-100-day-basis/
Beam Therapeutics Inc’s price action over the past 90 days can be seen via the chart below. BEAM: Daily RSI Analysis. BEAM’s RSI now stands at 0. BEAM and RSI may be exhibiting divergent ...
https://www.nasdaq.com/market-activity/stocks/beam
Beam Therapeutics Inc. Common Stock (BEAM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
https://finance.yahoo.com/quote/BEAM/
Beam Therapeutics to Participate in the Jefferies 2021 Virtual London Healthcare Conference. CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- …
https://www.cnbc.com/quotes/beam
Beam Therapeutics Inc. is a biotechnology company focused on developing precision genetic medicines based on its base editing technology, to providing life …
https://www.barrons.com/market-data/stocks/beam
Price at close. $ 88.99. 1.13. 1.29%. Oct 13, 2021 4:00 p.m. EDT. About Beam Therapeutics Inc. Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment ...
https://www.marketwatch.com/investing/Stock/BEAM
BEAM | Complete Beam Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
https://www.sec.gov/Archives/edgar/data/1745999/000156459021013190/beam-ex21_408.htm
beam therapeutics inc., galileo merger sub i, inc., galileo merger sub ii, llc, guide therapeutics, inc., shareholder representative services llc, as shareholders’ representative, and. the company holders signatory hereto (solely for purposes of section 2.12) dated as of february 22, 2021
https://stockanalysis.com/stocks/beam/company/
Company Description. Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an ...
Searching for Beam Therapeutics Inc Hours?
You can just click the links above. The info is collected for you.
